AIP.NASDAQArteris, INC

Form 4: Arteris Director Sells 63,118 Shares Under 10b5-1 Plan

Sentiment:

Insider Transaction Report


Arteris Director Saiyed Atiq Raza reported the sale of 63,118 common shares on August 5, 2025, executed under a pre-arranged 10b5-1 trading plan.

Worse than expectedA director's sale of 63,118 shares of common stock, even if pre-planned, reduces insider ownership and can be viewed as a negative signal by investors, potentially indicating a belief that the stock is fully valued or that the director needs liquidity.

Summary

  • Director Saiyed Atiq Raza reported the disposition of 63,118 shares of Arteris, Inc. (AIP) common stock.
  • The transaction occurred on August 5, 2025.
  • The shares were sold at a weighted average price of $13.074, with individual sale prices ranging from $12.35 to $14.20.
  • This sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by the Reporting Person on June 6, 2024.
  • Following this transaction, Saiyed Atiq Raza directly owns 20,839 shares of common stock.
  • Additionally, 590,000 shares are held indirectly through the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust, for which the Reporting Person serves as trustee.

Sentiment

Score: 3

Explanation: The filing reports a director's sale of a significant number of shares, which typically carries a negative sentiment as it reduces insider ownership, despite being executed under a pre-arranged 10b5-1 plan.

Positives

  • The sale was pre-planned under a Rule 10b5-1 trading plan, adopted on June 6, 2024, indicating a non-discretionary transaction rather than a reaction to new, adverse material information.

Negatives

  • Director Saiyed Atiq Raza disposed of 63,118 shares of Arteris, Inc. common stock on August 5, 2025.
  • The sale reduces the director's direct beneficial ownership to 20,839 shares, although significant indirect holdings remain.

Risks

  • Insider selling, even under a 10b5-1 plan, can sometimes be interpreted by the market as a lack of confidence in the company's near-term prospects or that the stock is fully valued, potentially leading to negative stock price pressure.

Future Outlook

No forward-looking statements or guidance regarding the company's financial performance or strategic direction are provided in this filing, beyond the execution of the pre-arranged stock sale.

Industry Context

This filing is an insider transaction report specific to a director's stock sale and does not provide information related to broader industry trends or competitive landscape.

Related Party Transactions

  • The indirect ownership of 590,000 shares is held by the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust, for which the Reporting Person serves as trustee.

Stakeholder Impact

  • Shareholders may perceive the director's sale as a negative signal, potentially impacting investor confidence and stock price due to reduced insider alignment.

Key Dates

DateDescription
June 6, 2024Rule 10b5-1 trading plan adopted by the Reporting Person.
August 5, 2025Date of disposition of common stock.
August 7, 2025Date of filing/signature of the Form 4.

Recommendation

hold

While the director's sale of shares reduces insider ownership, the transaction was executed under a pre-arranged 10b5-1 trading plan, which suggests it was not based on new, adverse material information. Investors should monitor future insider activity and company performance rather than reacting solely to this single, pre-planned disposition.

Keywords

Arteris, AIP, Form 4, Insider Trading, Stock Sale, Director, Saiyed Atiq Raza, 10b5-1 plan, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.